Goldman Sachs’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.2M | Buy |
228,475
+203,230
| +805% | +$2.33M | ﹤0.01% | 3881 |
|
|
2025
Q4 | $299K | Sell |
25,245
-11,730
| -32% | -$149K | ﹤0.01% | 5869 |
|
|
2025
Q3 | $440K | Buy |
+36,975
| New | +$491K | ﹤0.01% | 5580 |
|
|
2024
Q3 | – | Sell |
-8,043
| Closed | -$227K | – | 5929 |
|
|
2024
Q2 | $227K | Sell |
8,043
-3,104
| -28% | -$323K | ﹤0.01% | 5207 |
|
|
2024
Q1 | $3.34M | Buy |
11,147
+1,953
| +21% | +$583K | ﹤0.01% | 3450 |
|
|
2023
Q4 | $2.17M | Buy |
9,194
+1,249
| +16% | +$194K | ﹤0.01% | 3860 |
|
|
2023
Q3 | $1.19M | Buy |
7,945
+108
| +1% | +$17K | ﹤0.01% | 4149 |
|
|
2023
Q2 | $1.36M | Sell |
7,837
-1,182
| -13% | -$198K | ﹤0.01% | 4137 |
|
|
2023
Q1 | $1.14M | Buy |
9,019
+8,342
| +1,232% | +$1.88M | ﹤0.01% | 4292 |
|
|
2022
Q4 | $205K | Buy |
+677
| New | +$99.8K | ﹤0.01% | 5293 |
|
|
2022
Q1 | – | Sell |
-385
| Closed | -$55K | – | 6692 |
|
|
2021
Q4 | $55K | Buy |
385
+121
| +46% | +$22K | ﹤0.01% | 6247 |
|
|
2021
Q3 | $58K | Sell |
264
-970
| -79% | -$205K | ﹤0.01% | 6013 |
|
|
2021
Q2 | $286K | Buy |
1,234
+885
| +254% | +$225K | ﹤0.01% | 5548 |
|
|
2021
Q1 | $105K | Sell |
349
-156
| -31% | -$55.9K | ﹤0.01% | 5832 |
|
|
2020
Q4 | $190K | Sell |
505
-370
| -42% | -$130K | ﹤0.01% | 5105 |
|
|
2020
Q3 | $269K | Sell |
875
-119
| -12% | -$45.5K | ﹤0.01% | 4789 |
|
|
2020
Q2 | $373K | Buy |
994
+34
| +4% | +$9.63K | ﹤0.01% | 4523 |
|
|
2020
Q1 | $219K | Buy |
960
+173
| +22% | +$66.1K | ﹤0.01% | 4664 |
|
|
2019
Q4 | $416K | Sell |
787
-402
| -34% | -$218K | ﹤0.01% | 4603 |
|
|
2019
Q3 | $512K | Buy |
1,189
+634
| +114% | +$408K | ﹤0.01% | 4440 |
|
|
2019
Q2 | $662K | Buy |
555
+100
| +22% | +$120K | ﹤0.01% | 4252 |
|
|
2019
Q1 | $567K | Buy |
455
+45
| +11% | +$51.5K | ﹤0.01% | 4361 |
|
|
2018
Q4 | $388K | Sell |
410
-347
| -46% | -$418K | ﹤0.01% | 4507 |
|
|
2018
Q3 | $1.09M | Buy |
757
+540
| +249% | +$817K | ﹤0.01% | 4006 |
|
|
2018
Q2 | $351K | Sell |
217
-2,059
| -90% | -$3.54M | ﹤0.01% | 4701 |
|
|
2018
Q1 | $3.69M | Buy |
2,276
+1,144
| +101% | +$2.38M | ﹤0.01% | 3135 |
|
|
2017
Q4 | $1.9M | Buy |
+1,132
| New | +$1.5M | ﹤0.01% | 3841 |
|
|
2017
Q3 | – | Sell |
-864
| Closed | -$965K | – | 6734 |
|
|
2017
Q2 | $965K | Buy |
+864
| New | +$714K | ﹤0.01% | 4491 |
|
|
2016
Q3 | – | Sell |
-879
| Closed | -$639K | – | 7079 |
|
|
2016
Q2 | $639K | Buy |
879
+606
| +222% | +$418K | ﹤0.01% | 4615 |
|
|
2016
Q1 | $163K | Sell |
273
-285
| -51% | -$146K | ﹤0.01% | 5775 |
|
|
2015
Q4 | $319K | Buy |
558
+15
| +3% | +$9.94K | ﹤0.01% | 5300 |
|
|
2015
Q3 | $304K | Sell |
543
-198
| -27% | -$143K | ﹤0.01% | 5595 |
|
|
2015
Q2 | $589K | Buy |
741
+1
| +0.1% | +$827 | ﹤0.01% | 5016 |
|
|
2015
Q1 | $616K | Sell |
740
-161
| -18% | -$125K | ﹤0.01% | 4931 |
|
|
2014
Q4 | $649K | Sell |
901
-55
| -6% | -$43K | ﹤0.01% | 5032 |
|
|
2014
Q3 | $663K | Sell |
956
-51
| -5% | -$41.3K | ﹤0.01% | 5019 |
|
|
2014
Q2 | $849K | Sell |
1,007
-67
| -6% | -$66.7K | ﹤0.01% | 4838 |
|
|
2014
Q1 | $1.75M | Buy |
+1,074
| New | +$1.3M | ﹤0.01% | 4101 |
|
Other funds holding CBIO
BI
FFM
VA
FIS
VPC
OM
TCM
VCM